RAET1E and nasopharyngeal carcinoma: This could be related to a favorable prognosis gained from IMRT and combined chemotherapy, which necessitates the enrollment of a larger number of patients with NPC to demonstrate the independent prognostic value of expression of ULBP4 in patients with NPC.